Details for 2020177822

Up to date per 03.04.2026

Actions

Title / Product Name

ERTUGLIFLOZIN ZUR VERWENDUNG BEI DER BEHANDLUNG VON HERZINSUFFIZIENZ IN DIABETESPATIENTEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020177822

EP Publication Number

3735975

E-Number

1862932

Language

PCT Number

Publication Date

11.11.2020 A

03.12.2025 B1

Registration Date

03.12.2025

AT Publication Date

15.12.2025

Application Date

06.03.2017

Registration Number

Priorities

11.03.2016

201662306907 P

IPC

A61K 31/7048 20060101AFI20200924BHEP

Maximum Duration of Protection

06.03.2037

Owner

Merck Sharp & Dohme LLC126 East Lincoln Avenue Rahway, New Jersey 07065US

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

No representatives present

Inventor

LAURING, Brett126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

ENGEL, Samuel, S.126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

RUSNAK, James, M.235 E. 42nd Street New York, New York 10017US

TERRA, Steven, G.235 E. 42nd Street New York, New York 10017US

Information about Fees